Abstract:Systems biology has emerged over the last decade. Driven by the advances in sophisticated measurement technology the research community generated huge molecular biology data sets. These comprise rather static data on the interplay of biological entities, for instance protein-protein interaction network data, as well as quite dynamic data collected for studying the behavior of individual cells or tissues in accordance with changing environmental conditions, such as DNA microarrays or RNA sequencing. Here we bri… Show more
“…There is no overlap of genes or biological pathways reported in the study of Alcaraz et al [34] with those identified in our work. Out of the 11 new genes proposed by these authors seven genes (CTNNB1, GNAQ, GRB2, OPTN, TP53, UBE2K and YWHAB) have p -value of < 0.01 but were not significantly expressed in all tissue types so they were not included into our 531 SDEGs.…”
Section: Resultssupporting
confidence: 47%
“…Studying molecular mechanisms of HD Kalathur et al [33] found indications for potential relevance of the cell cycle processes, RNA splicing, Wnt and ErbB signaling, and proposed a candidate set of 24 novel genetic modifiers. Alcaraz et al [34] used the GSE3790 dataset in one of the case studies to prove the efficiency of their KeyPathwayMiner computational tool. An interesting moment in their analysis is that some of the proposed new HD-relevant genes (termed “exception” genes) are statistically insignificant.…”
Huntington's disease is a progressive neurodegenerative disorder characterized by motor disturbances, cognitive decline, and neuropsychiatric symptoms. In this study, we utilized network-based analysis in an attempt to explore and understand the underlying molecular mechanism and to identify critical molecular players of this disease condition. Using human post-mortem microarrays from three brain regions (cerebellum, frontal cortex and caudate nucleus) we selected in a four-step procedure a seed set of highly modulated genes. Several protein–protein interaction networks, as well as microRNA–mRNA networks were constructed for these gene sets with the Elsevier Pathway Studio software and its associated ResNet database. We applied a gene prioritizing procedure based on vital network topological measures, such as high node connectivity and centrality. Adding to these criteria the guilt-by-association rule and exploring their innate biomolecular functions, we propose 19 novel genes from the analyzed microarrays, from which CEBPA, CDK1, CX3CL1, EGR1, E2F1, ERBB2, LRP1, HSP90AA1 and ZNF148 might be of particular interest for experimental validation. A possibility is discussed for dual-level gene regulation by both transcription factors and microRNAs in Huntington's disease mechanism. We propose several possible scenarios for experimental studies initiated via the extra-cellular ligands TGFB1, FGF2 and TNF aiming at restoring the cellular homeostasis in Huntington's disease.
“…There is no overlap of genes or biological pathways reported in the study of Alcaraz et al [34] with those identified in our work. Out of the 11 new genes proposed by these authors seven genes (CTNNB1, GNAQ, GRB2, OPTN, TP53, UBE2K and YWHAB) have p -value of < 0.01 but were not significantly expressed in all tissue types so they were not included into our 531 SDEGs.…”
Section: Resultssupporting
confidence: 47%
“…Studying molecular mechanisms of HD Kalathur et al [33] found indications for potential relevance of the cell cycle processes, RNA splicing, Wnt and ErbB signaling, and proposed a candidate set of 24 novel genetic modifiers. Alcaraz et al [34] used the GSE3790 dataset in one of the case studies to prove the efficiency of their KeyPathwayMiner computational tool. An interesting moment in their analysis is that some of the proposed new HD-relevant genes (termed “exception” genes) are statistically insignificant.…”
Huntington's disease is a progressive neurodegenerative disorder characterized by motor disturbances, cognitive decline, and neuropsychiatric symptoms. In this study, we utilized network-based analysis in an attempt to explore and understand the underlying molecular mechanism and to identify critical molecular players of this disease condition. Using human post-mortem microarrays from three brain regions (cerebellum, frontal cortex and caudate nucleus) we selected in a four-step procedure a seed set of highly modulated genes. Several protein–protein interaction networks, as well as microRNA–mRNA networks were constructed for these gene sets with the Elsevier Pathway Studio software and its associated ResNet database. We applied a gene prioritizing procedure based on vital network topological measures, such as high node connectivity and centrality. Adding to these criteria the guilt-by-association rule and exploring their innate biomolecular functions, we propose 19 novel genes from the analyzed microarrays, from which CEBPA, CDK1, CX3CL1, EGR1, E2F1, ERBB2, LRP1, HSP90AA1 and ZNF148 might be of particular interest for experimental validation. A possibility is discussed for dual-level gene regulation by both transcription factors and microRNAs in Huntington's disease mechanism. We propose several possible scenarios for experimental studies initiated via the extra-cellular ligands TGFB1, FGF2 and TNF aiming at restoring the cellular homeostasis in Huntington's disease.
“…Therefore, efforts are being made to create principled and biologically meaningful representations of these large-scale data in models that are flexible enough to Systems Biology modeling has been widely used in biology for many years; it frequently comprises just a single data type (for example, mRNA level or protein concentration) or uses small numbers of molecules or canonical pathways and rarely takes spatial constrains into consideration. More recently, integrative methods have begun to overlay multiple data sources onto these models, for example, visualizing mRNA expression data in the context of protein-interaction networks (Alcaraz et al 2012;Li et al 2012) or proteomic data (Hallock and Thomas 2012), but these methods of data integration do not implicitly model the relationships between the different data types, and the functional insight obtained is limited.…”
mRNA translation, or protein synthesis, is a major component of the transformation of the genetic code into any cellular activity. This complicated, multistep process is divided into three phases: initiation, elongation, and termination. Initiation is the step at which the ribosome is recruited to the mRNA, and is regarded as the major rate-limiting step in translation, while elongation consists of the elongation of the polypeptide chain; both steps are frequent targets for regulation, which is defined as a change in the rate of translation of an mRNA per unit time. In the normal brain, control of translation is a key mechanism for regulation of memory and synaptic plasticity consolidation, i.e., the off-line processing of acquired information. These regulation processes may differ between different brain structures or neuronal populations. Moreover, dysregulation of translation leads to pathological brain function such as memory impairment. Both normal and abnormal function of the translation machinery is believed to lead to translational up-regulation or down-regulation of a subset of mRNAs. However, the identification of these newly synthesized proteins and determination of the rates of protein synthesis or degradation taking place in different neuronal types and compartments at different time points in the brain demand new proteomic methods and system biology approaches. Here, we discuss in detail the relationship between translation regulation and memory or synaptic plasticity consolidation while focusing on a model of cortical-dependent taste learning task and hippocampal-dependent plasticity. In addition, we describe a novel systems biology perspective to better describe consolidation.
“…This approach followed the work by Zhang et al [50] for mapping other species' gene expression data to a human PPI network. We utilized the KeyPathwayMiner program in Cytoscape 2.8 to obtain the liver fibrosis-relevant sub-network [51]–[53]. KeyPathwayMiner attempts to find maximally connected sub-networks for the input query genes with gene expression data using the ant-colony optimization algorithm [51].…”
Section: Methodsmentioning
confidence: 99%
“…We utilized the KeyPathwayMiner program in Cytoscape 2.8 to obtain the liver fibrosis-relevant sub-network [51]–[53]. KeyPathwayMiner attempts to find maximally connected sub-networks for the input query genes with gene expression data using the ant-colony optimization algorithm [51]. We used KeyPathwayMiner with ant-colony optimization algorithm , node exceptions (K) set to 100 , and case exceptions (L) set to 0 .…”
Toxic liver injury causes necrosis and fibrosis, which may lead to cirrhosis and liver failure. Despite recent progress in understanding the mechanism of liver fibrosis, our knowledge of the molecular-level details of this disease is still incomplete. The elucidation of networks and pathways associated with liver fibrosis can provide insight into the underlying molecular mechanisms of the disease, as well as identify potential diagnostic or prognostic biomarkers. Towards this end, we analyzed rat gene expression data from a range of chemical exposures that produced observable periportal liver fibrosis as documented in DrugMatrix, a publicly available toxicogenomics database. We identified genes relevant to liver fibrosis using standard differential expression and co-expression analyses, and then used these genes in pathway enrichment and protein-protein interaction (PPI) network analyses. We identified a PPI network module associated with liver fibrosis that includes known liver fibrosis-relevant genes, such as tissue inhibitor of metalloproteinase-1, galectin-3, connective tissue growth factor, and lipocalin-2. We also identified several new genes, such as perilipin-3, legumain, and myocilin, which were associated with liver fibrosis. We further analyzed the expression pattern of the genes in the PPI network module across a wide range of 640 chemical exposure conditions in DrugMatrix and identified early indications of liver fibrosis for carbon tetrachloride and lipopolysaccharide exposures. Although it is well known that carbon tetrachloride and lipopolysaccharide can cause liver fibrosis, our network analysis was able to link these compounds to potential fibrotic damage before histopathological changes associated with liver fibrosis appeared. These results demonstrated that our approach is capable of identifying early-stage indicators of liver fibrosis and underscore its potential to aid in predictive toxicity, biomarker identification, and to generally identify disease-relevant pathways.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.